Longevity Docs (newsletter)
Longevity Medicine Enters Adulthood: 'Back to Medicine' and the End of the Wild West
A sector maturity signal: less hype, more real medicine — protocols, traceability, and clinical oversight.
Latest
Longevity Medicine News
Research, clinical trials, regulatory updates, and industry analysis from the longevity medicine world.
openPR
LifeWellMD Launches a 'Men's Performance & Longevity Lab': Longevity Gets Niche-Specific
A clinic announces a longevity program focused on men: coordinated assessment + roadmap + follow-up. A signal of the sector's 'productization.'
BBC Worklife Peer-reviewed
The Business of 'Not Aging': The Gap Between What's Sold and What Science Supports
BBC examines the longevity industry boom: extreme diagnostics, expensive programs, and the key question — what part is real prevention and what part is marketing?
The Atlantic Peer-reviewed
'The Longevity Scam': The Critique the Sector Needs (If It Wants to Last)
A sharp critique of 'longevity marketing': the future is measurable prevention, clear boundaries, and fewer interventions without robust evidence.
ArentFox Schiff (press release)
When an Am Law 100 Firm Creates a 'Longevity & Healthspan' Group, It's No Longer Niche
An Am Law 100 firm launches a group dedicated to longevity/healthspan: a signal that regulation, privacy, and IP are becoming the real battleground.
Entrepreneur
Biograph and the 'Diagnostic Day': Why Luxury Is No Longer the Product
An inside look at Biograph: 6 hours, 30+ tests, and 1,000+ data points. The clinical question isn't 'what do you measure' — it's what decisions you change with the data.
Fitt Insider
Sequel Brands + Lifeforce Launch Ultimate Longevity Center: The 'Gym-as-Clinic' Goes Franchise
A new franchise concept of 'longevity studios' blends recovery therapies (red light, HBOT, cold plunge) with clinical upsells (biomarkers, NAD, GLP-1, HRT, peptides, IV).